share_log

Cannabis REIT IIPR Buys Florida Property For $43M With Reconstruction Reimbursement, Expands Lease With Ayr Wellness

Cannabis REIT IIPR Buys Florida Property For $43M With Reconstruction Reimbursement, Expands Lease With Ayr Wellness

大麻股REIT IIPR以重建補償方式購入佛羅里達州資產,與Ayr Wellness擴大租約。
Benzinga ·  06/10 21:54

Cannabis REIT Innovative Industrial Properties, Inc. (NYSE:IIPR) confirmed Monday it has closed on the acquisition of a 16-acre property comprising 145,000 square feet of industrial space in Ocala, Florida. Under the deal, it has entered into a long-term, triple-net lease with a subsidiary of AyrWellness Inc. (OTCQX:AYRWF).

紐交所大麻股房地產投資信託公司Innovative Industrial Properties, Inc. (NYSE:IIPR)證實,週一關閉了對佛羅里達州奧卡拉(Ocala)一塊佔地16英畝、由145,000平方英尺工業空間組成的地產的收購。根據交易,它已與AyrWellness Inc.(OTCQX:AYRWF)的子公司簽訂了長期三重淨租賃合同。

The purchase price for the property was $13.0 million ($90 per square foot). Ayr is expected to redevelop one building on the property comprising 98,000 square feet of industrial space for expected use as a regulated cannabis cultivation facility upon completion, for which IIP has agreed to provide reimbursement of up to $30.0 million. Assuming full reimbursement for the construction, IIP's total investment in the property is expected to be $43.0 million (excluding transaction costs).

該物業的購買價格爲1300萬美元(每平方英尺90美元)。預計Ayr將在物業上重新開發一個包含98,000平方英尺工業空間的建築,在完成後預計將用於監管的大麻種植設施,對此,IIP同意提供最高3000萬美元的報銷。假設全額報銷建設費用,IIP在該物業的總投資預計將達到4300萬美元(不包括交易成本)。

In addition to this property, IIP owns and leases to Ayr one processing facility in Ohio comprising 11,000 square feet.

除了這個物業,IIP還擁有並出租了一處位於俄亥俄州的加工設施,佔地11,000平方英尺,租賃給Ayr。

Huge Potential In Florida

佛羅里達州的巨大潛力。

Ayr, a vertically integrated cannabis operator in the U.S, operating in eight states with 18 production facilities and 91 dispensary locations. Recently, the company disclosed its first quarter 2024 total revenues of $118 million and adjusted EBITDA of $29 million. In the Sunshine State alone, Ayr operates 64 dispensary locations, with 745,000 square feet of existing production capacity (excluding this property).

Ayr是美國的垂直整合大麻運營商,在8個州開展業務,擁有18個生產設施和91個藥店。最近,公司披露了2024財年第一季度的總收入達1.18億美元,調整後的EBITDA爲2900萬美元。僅在陽光州,Ayr就經營着64個藥店,擁有745,000平方英尺的現有生產能力(不包括這個物業)。

Florida represents the largest medical-use cannabis market in the United States, with the program having received 71% voter approval in 2019. According to the Florida Office of Medical Marijuana Use (OMMU), as of May 31, 2024, there were over 880,000 qualified patients and over 2,300 qualified physicians in the medical-use cannabis program, and BDSA reported 2023 regulated sales of $2.6 billion. Floridians are expected to vote on adult-use legalization of cannabis in November 2024, which requires 60% approval to pass. Under the initiative, existing licensed medical cannabis operators are expected to be authorized to sell cannabis to adults for personal use. The Florida state legislature could provide the licensure of other entities to cultivate and sell cannabis for adult use.

佛羅里達州代表美國最大的醫用大麻市場,2019年該計劃獲得71%的選民支持。根據佛羅里達醫療大麻管理辦公室(OMMU)的數據,截至2024年5月31日,醫用大麻計劃有超過88萬合格患者和超過2,300名合格醫生,BDSA報道2023年的受監管銷售額爲26億美元。預計佛羅里達人將在2024年11月投票通過大麻成年人使用的合法化,需要60%的批准率通過。在此倡議下,預計現有持牌醫用大麻運營商將獲得授權,向成年人出售大麻以供個人使用。佛羅里達州立法機構可能會頒發許可證給其他實體,種植和銷售成年人使用的大麻。

Price Action

股價變動

IIPR shares traded 0.78% lower at $106.05 during Monday's pre-market session.

在週一的盤前交易中,IIPR股票下跌0.78%,報106.05美元。

Promotion of Benzinga's Cannabis Market Spotlight event in New Jersey.
Promotion of Benzinga's Cannabis Market Spotlight event in New Jersey.
Benzinga在新澤西的大麻市場聚光活動的推廣。

Join the Benzinga Cannabis Market Spotlight in New Jersey on June 17th! Grow your business, raise money and capitalize on the booming NJ recreational market. Don't miss this must-attend event in New Brunswick. Secure your tickets now. Very few spots are left. Use the code "JAVIER20" for 20% off

6月17日,加入Benzinga大麻市場聚焦照明活動! 發展您的業務,籌集資金並利用NJ休閒市場的繁榮。 不要錯過這個在新不倫瑞克的必參活動。 立即確保您的門票。 剩下的位置不多了。使用“JAVIER20”代碼可享受20%的折扣

Photo: Courtesy of HTWE via Shutterstock

圖片:HTWE通過Shutterstock提供

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論